|
BPNT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.068560E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.707590E-01 |
| Normal-vs-Stage2 |
3.179900E-02 |
| Normal-vs-Stage3 |
1.967350E-01 |
| Normal-vs-Stage4 |
5.332000E-01 |
| Stage1-vs-Stage2 |
2.050400E-01 |
| Stage1-vs-Stage3 |
8.588000E-01 |
| Stage1-vs-Stage4 |
8.361800E-01 |
| Stage2-vs-Stage3 |
3.087600E-01 |
| Stage2-vs-Stage4 |
2.856200E-01 |
| Stage3-vs-Stage4 |
7.532000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.004500E-02 |
| Normal-vs-AfricanAmerican |
1.933370E-01 |
| Normal-vs-Asian |
7.876800E-01 |
| Caucasian-vs-AfricanAmerican |
1.630280E-02 |
| Caucasian-vs-Asian |
3.315200E-01 |
| AfricanAmerican-vs-Asian |
1.610830E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.844000E-02 |
| Normal-vs-Female |
1.787030E-01 |
| Male-vs-Female |
3.583000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.114400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.640400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.447200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.358000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.631560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.343800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.396400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.162800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.884000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.110000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.726600E-01 |
| Classical-VS-Follicular |
2.576700E-04 |
| Classical-VS-Other |
2.704800E-01 |
| Classical-VS-Normal |
6.321200E-01 |
| Tall-VS-Follicular |
3.336300E-02 |
| Tall-VS-Other |
3.077400E-01 |
| Tall-VS-Normal |
7.300200E-01 |
| Follicular-VS-Other |
9.096200E-01 |
| Follicular-VS-Normal |
1.081610E-03 |
| Other-VS-Normal |
1.492160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.865880E-02 |
| Normal-vs-N1 |
1.143230E-01 |
| N0-vs-N1 |
9.210000E-01 |
|
|
